Pharma's Premier EPI Database Launches New Forecast Period and Disease I... (omemarshall@dresources.com target

Pharma's Premier EPI Database Launches New Forecast Period and Disease Indications

Date:5/7/2009

om>emarshall@dresources.com" target="_new">emarshall@dresources.com.

About Decision Resources

Decision Resources (www.DecisionResources.com) is a world leader in market research publications, advisory services and consulting designed to help clients shape strategy, allocate resources and master their chosen markets. Decision Resources is a Decision Resources, Inc. company.

About Decision Resources, Inc.

Decision Resources, Inc. is a cohesive portfolio of companies that offers best-in-class, high-value information and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources, Inc. at www.DecisionResourcesInc.com.

All company, brand or product names contained in this document may be trademarks or registered trademarks of their respective holders.

    For more information, contact:

    Natalia Morales           Elizabeth Marshall
    Decision Resources        Decision Resources, Inc.
    781-296-2691              781-296-2563
    nmorales@dresources.com   emarshall@dresources.com

SOURCE Decision Resources
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2
Related medicine news :

1. Pharmasset to Present at Two Upcoming Investor Conferences
2. Pharmasset to Present at Two Upcoming Investor Conferences
3. ePharmaSolutions Adds Several Industry Clinicians to its Rater Certification and Data Monitoring Department
4. Pharmasset to Present at the 27th Annual JPMorgan Healthcare Conference
5. Parkland Health & Hospital System Rolls Out Innovations PharmASSIST Technology Platform Across Nine Pharmacy Sites
6. PharmaSmart International, Inc. Redefines Blood Pressure Management through Technology and Pharmacy Focused Patient Services
7. Pharmasset to Webcast an Investor Event from the AASLD Meeting
8. Pharmasset Reports Financial Results for Quarter Ended March 31, 2008
9. Pharmasset to Present at the Rodman & Renshaw Healthcare Conference on Tuesday, May 20th
10. Pharmasset Appoints Patrick T. Higgins as Executive Vice President, Marketing & Sales
11. Pharmasset Presents R7128 14-Day Monotherapy Study Results for the Treatment of Chronic Hepatitis C

Post Your Comments:

(Date:12/5/2009)NEW ORLEANS, Dec. 5 Leukemia and myeloproliferative disorders are serious and often deadly blood cancers. Research presented today at the 51st Annual Meeting of the American Society of Hematology int

(Date:12/5/2009)AVIVA today announced the launch of International Solutions, an innovative new international private medical insurance plan which follows the acclaimed modular design of its UK equivalent. In addition

(Date:12/4/2009)NEW YORK, Dec. 4 Care Investment Trust Inc. (NYSE: CRE ) ("Care" or the "Company") today announced that its Board of Directors has declared a dividend of $0.17 per share of common stock. The div

(Date:12/4/2009)WASHINGTON, Dec. 4 The American Association of Homes and Services for the Aging (AAHSA) applauds the Senate for ensuring that the Community Living and Supportive Services (CLASS) provisions remain i

(Date:12/4/2009)ANAHEIM, Calif., Dec. 4 Pamela Bowen, Chief Information Officer at Crescent Healthcare, was selected as a finalist for the "Chief Innovation Officer" Appy Award for transforming Crescent,s business w

[0] Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders [0] AVIVA's Private Health Insurance Products Solutions Go International [0] Care Investment Trust Inc. Declares Quarterly Dividend of $0.17 Per Share [0] Statement from AAHSA CEO Larry Minnix on the Failure of the Thune Amendment [0] Crescent CIO '09 Dreamforce Conference Speaker and Award Finalist

...inuity disturbance impairs endogenous pain-inhibit...en//. This supports a possible pathophysiologic ro... to a study published in the April 1st issue of th...ere studied polysomnographically for seven nights....

...f screening women in Ghana for early signs of cerv...t the same visit appears to be safe, acceptable to...earcher at the Stanford University School of Medic...ntries, said Paul Blumenthal, MD, MPH, acting prof...

...o a type of bacteria found in soil boosts happines...ctions// in people who are depressed and prone to ...led by Chris Lowry at Bristol University treated l...tion of BBC News. However, they said more w...

...overnments in India's northeastern region have sou...y from Bangladesh and Myanmar after the two countr...id Monday. Tripura, Assam, Mizoram, Manipu...y from the two countries. 'We are worried...

...her ‘ bitter’ feelings, a grieving widow has deci...nd caught a fatal infection, to court. // Gre...d speak to a lawyer about the circumstances that l... hospital for a blood transfusion almost a month...

...team of doctors attempting to conduct tests on Mt ...wallow a bitter dose after the Nepal government sa... Aviation, Space and Extreme Environment Medicine ...ygen in their own blood on the summit as well as t...

Other Medicine News:Health News:New Study in SLEEP Finds That Sleep Disturbance Increases Spontaneous Pain in Women 2 Health News:1-visit Screening, Prevention for Cervical Cancer Holds Promise 2

New Study in SLEEP Finds That Sleep Disturbance Increases Spontaneous Pain in Women 1-visit Screening, Prevention for Cervical Cancer Holds Promise Exposure to a Soil Bacterium can Boost Happiness Northeast States Sound Bird Flu Alert Embittered Widow to Sue Hospital British Doctors on Everest Mission Get Bitter Dose

(Date:12/4/2009)WASHINGTON, Dec. 4 Chemistry World recently highlighted a new report published by the Pharmaceutical Research and Manufacturers of America ( PhRMA ) that identifies 97 new drugs and vaccines in

(Date:12/4/2009)SAN DIEGO, Calif., Dec. 4 Suneva Medical, a privately-held aesthetic medical device company, today announced the appointment of Philip Ranker as Vice President and Chief Financial Officer. In this r

(Date:12/4/2009)TARRYTOWN, N.Y., Dec. 4 Bayer Diabetes Care today announced the three grand prize winners of Bayer,s "Express Your Simple Win Creativity Contest." Nick Jonas, of the Jonas Brothers, selected the winn

Breaking Medicine Technology:U.S. Pharmaceutical Companies Developing 97 New Drugs and Vaccines to Fight HIV/AIDS 2 Suneva Medical Announces Corporate Developments Including Appointment of Philip Ranker as Chief Financial Officer 2 Suneva Medical Announces Corporate Developments Including Appointment of Philip Ranker as Chief Financial Officer 3 Suneva Medical Announces Corporate Developments Including Appointment of Philip Ranker as Chief Financial Officer 4 Bayer 'Express Your Simple Win Creativity Contest' Grand Prize Winners Announced 2 Bayer 'Express Your Simple Win Creativity Contest' Grand Prize Winners Announced 3 Baylor Dallas Opens Nations First Neurosurgical OR Suite Featuring BrainSUITE iMRI GE Healthcare MR Surgical Technology 48035 1 Baylor Dallas Opens Nations First Neurosurgical OR Suite Featuring BrainSUITE iMRI GE Healthcare MR Surgical Technology 48035 2 Arena Pharmaceuticals to Present at the 8th Annual Needham Life Sciences Conference 12483 1 Arena Pharmaceuticals to Present at the 8th Annual Needham Life Sciences Conference 12483 2 Arena Pharmaceuticals to Present at the 8th Annual Needham Life Sciences Conference 12483 3 Isis Pharmaceuticals to Present at Needhams 8th Annual Life Sciences Conference 48033 1

[0] U.S. Pharmaceutical Companies Developing 97 New Drugs and Vaccines to Fight HIV/AIDS [0] Suneva Medical Announces Corporate Developments Including Appointment of Philip Ranker as Chief Financial Officer [0] Bayer 'Express Your Simple Win Creativity Contest' Grand Prize Winners Announced

...nd PHILADELPHIA, June 30 ,GlaxoSmithKline (NYSE: ...g,its application to the U.S. Food and Drug Admini...ccine to prevent cervical cancer., GSK has submit... their,Complete Response Letter, received in Decem... GSK,s Phase III pivotal efficacy study, HPV-008, ...

...rine,s Second Phase II Bavituximab Cancer Trial Is...mab in Combination with Carboplatin and ...June 30 Peregrine,Pharmaceuticals, Inc. (Nasdaq: ... dosing has begun in a Phase II trial designed to ... combination with chemotherapy in patients,with no...

Other Medicine Technology:GlaxoSmithKline Responds to FDA on CERVARIX(R) and Plans to Submit Final Study Data for Approval 2 GlaxoSmithKline Responds to FDA on CERVARIX(R) and Plans to Submit Final Study Data for Approval 3 Peregrine Pharmaceuticals Doses First Patient in Phase II Trial of Bavituximab in Patients With Non-Small Cell Lung Cancer 2 Peregrine Pharmaceuticals Doses First Patient in Phase II Trial of Bavituximab in Patients With Non-Small Cell Lung Cancer 3 Peregrine Pharmaceuticals Doses First Patient in Phase II Trial of Bavituximab in Patients With Non-Small Cell Lung Cancer 4

GlaxoSmithKline Responds to FDA on CERVARIX(R) and Plans to Submit Final Study Data for Approval Peregrine Pharmaceuticals Doses First Patient in Phase II Trial of Bavituximab in Patients With Non-Small Cell Lung Cancer

O'Brien Suprapubic Peel-Away® Access Set

Pereyra Ligature Carrier '75

Stratasis Urethral Sling,Freeze-Dried

van Andel Catheter

Medicine Products:

O'Brien Suprapubic Peel-Away® Access Set Pereyra Ligature Carrier '75 Stratasis Urethral Sling,Freeze-Dried van Andel Catheter

Pharma's Premier EPI Database Launches New Forecast Period and Disease I...(omemarshall@dresources.com target _new...),Health